BDBM357274 2-(((1s,4s)-4-((4-(5- fluoropyridin-3-yl)-5- (methylthio)-3-phenyl-1H- pyrazol-1- yl)methyl)cyclohexyl) methoxy)acetic acid::US10214518, Compound 135
SMILES: CSc1c(c(nn1C[C@@H]1CC[C@H](COCC(O)=O)CC1)-c1ccccc1)-c1cncc(F)c1
InChI Key: InChIKey=KAHKWAPEWNQHDG-HDICACEKSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prion protein (Homo sapiens (Human)) | BDBM357274 (2-(((1s,4s)-4-((4-(5- fluoropyridin-3-yl)-5- (meth...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 220 | n/a | n/a | n/a | n/a | n/a | n/a |
Arena Pharmaceuticals, Inc. US Patent | Assay Description Blood collected from healthy human volunteers in aqueous trisodium citrate solution was centrifuged at 150 g for 15 min and the upper layer was recov... | US Patent US10214518 (2019) BindingDB Entry DOI: 10.7270/Q2T155XG | |||||||||||
More data for this Ligand-Target Pair |